AtriCure (ATRC) 10-Q2024 Q2 Quarterly report

Filed: 31 Jul 24, 11:39am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: adjournment, asserting, augmented, background, ball, beneficial, bring, card, chair, Chancery, China, clarify, color, competing, compulsory, consent, contrary, Court, Delaware, deliver, delivered, delivery, derivative, DGCL, director, disqualified, district, doctrine, duty, endoscope, energy, entirety, entity, Exhibit, extent, facilitate, fact, fiduciary, focusing, foregoing, forum, fullest, governed, grew, iii, indemnification, indemnify, indemnitee, independence, insertion, July, jurisdiction, list, manner, ministerial, National, NMPA, nominated, nominating, nomination, nominee, nonrecurring, notice, order, owner, ownership, permitted, proceeding, prohibition, proxy, publish, purport, qualified, questionnaire, Restated, secretary, serving, soliciting, stand, standing, stockholder, strength, text, thereof, thermal, threatened, tip, vacuum, vote, white

Removed: bolstered, generation

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated ATRC transcripts

ATRC similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of AtriCure, Inc. (Company) on Form 10-Q for the quarter ended June 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (Report), I, Michael H. Carrel, President and Chief Executive Officer and Principal Executive Officer of the Company, certify, pursuant to Rule 13a–14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: July 31, 2024

	By:	/s/ Michael H. Carrel
		Michael H. Carrel
		President and Chief Executive Officer
		(Principal Executive Officer)

A signed original of this written statement or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to AtriCure, Inc. and will be retained by AtriCure, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the report or as a separate disclosure document.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.